Another COVID-19 vaccine is right around the corner

Late last week, Johnson & Johnson announced topline efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, highlighting that the single-dose COVID-19 vaccine in development at its Janssen Pharmaceutical Companies met all primary and key secondary endpoints.